Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to four years. The protein mirrors the silent buildup of amyloid and tau in the brain long before memory loss appears. This advance could speed up preventive drug trials and eventually guide personalized care.
Quelle: ScienceDaily | Asthma
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Asthma
- Scientists may have found a pill for sleep apnea
- Simple blood test can forecast Alzheimer’s years before memory loss
- A hidden breathing problem may be behind chronic fatigue’s crushing exhaustion
- COVID vaccine linked to fewer infections and allergies in kids with eczema
- Doctors tested a common drug on COVID. The results are stunning
- New inhaler halves childhood asthma attacks
- One number at age 7 could predict how long you live
- More likely to be struck by lightning than get tetanus. So why the boosters?
- Invisible ID: How a single breath could reveal your health—and your identity
- People with critical cardiovascular disease may benefit from palliative care
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
